Search Results
Dec 09, 2025, 12:35 ET Polaris Slingshot Announces 2026 Model Year Lineup, Reveals Stunning Grand Touring Limited-Edition Model and Vibrant New Colorways
mounted buttons.Designed from Slingshot's top-tier R model, the limited-edition Grand Touring features a Polaris-built ProStar 2.0L four-cylinder engine – putting out 204 horsepower. Whether operating a manual or AutoDrive transmission, two drive modes, Comfort and Slingshot, offer
More news about: Polaris Slingshot
Dec 09, 2025, 12:21 ET Zendure sorgt für Weihnachtsstimmung mit SolarFlow-Angeboten
SolarFlow-Serie. Das System besteht aus einem intelligenten 800 W Wechselrichter und einer 1,92 kWh Batterie, die sich flexibel mit bis zu fünf AB2000X- oder AB2000L-Speichern auf maximal 11,52 kWh erweitern lässt.Das effiziente 48 V LiFePO₄-System reduziert Energieverluste um bis zu 25 Prozent. Zwei MPPTs mit
More news about: Zendure DE GmbH
Dec 09, 2025, 11:57 ET FOX NATION TAPS ZACHARY LEVI FOR NEW DOCUDRAMA "DAVID: KING OF ISRAEL" SLATED FOR EARLY 2026
figures and why he continues to endure as "a man after God's own heart." The series was created by Warm Springs Productions with executive producers David L. Cunningham, Marc Pierce, Chris Richardson and Bridger Pierce. Zachary Levi is an acclaimed actor, singer, and dancer, earning a Tony nomination
More news about: Fox News Network, LLC
Dec 09, 2025, 11:38 ET El Grupo Menarini presenta datos de la combinación de fase 2 de Elacestrant (ORSERDU®) en cáncer de mama
presentación: viernes, 12 de diciembre de 2025, 12.30 – 2.00 PMLocalización: Henry B. Convention CenterPonente: Sara L. SammonsTítulo de la presentación: Hormonal receptor (HR)-positive HER2 negative breast cancer patients treated with preoperative Elacestrant
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 11:03 ET Pew Funds 7 New Biomedical Research Collaborations
Andrew L. Goodman, Ph.D., 2013 Pew biomedical scholar, Yale School of Medicine
More news about: The Pew Charitable Trusts
Dec 09, 2025, 11:03 ET Pew fomenta 7 novas colaborações em pesquisa biomédica
Andrew L. Goodman, Ph.D., da classe de 2013 do Pew biomedical scholar, Yale School of Medicine
More news about: The Pew Charitable Trusts
Dec 09, 2025, 11:03 ET Pew financia 7 nuevas colaboraciones en investigación biomédica
Andrew L. Goodman, Ph.D., académico del programa Pew en biomedicina del año 2013, Facultad de Medicina de Yale
More news about: The Pew Charitable Trusts
Dec 09, 2025, 11:00 ET Aragon Research Unveils Hot Vendors in Learning, 2025: AI Learning Assistants Drive New Era of Skills Mastery
integrated ecosystems. Hot Vendors are differentiating themselves by offering AI-based content creation and intelligent learning assistants for learners, L&D professionals, and leaders. These new capabilities help organizations interpret learning data to improve performance and reduce risk."The future
More news about: Aragon Research
Dec 09, 2025, 10:56 ET BestQool Launches Christmas Campaign Crossing Into 2026 Before the Next Wave of New Product Updates
[email protected][1] Finkelstein, L. (2013). The Benefits of Red Light Therapy. Journal of Cosmetic Dermatology, 12(4), 278-284.[2] Naeser, M. A., et al. (2014). Red/NIR
More news about: Bestqool
Dec 09, 2025, 10:21 ET ADI Foundation Announces Launch of ADI Chain's Mainnet and ADI Utility Token
ADI Chain is the first institutional-grade L2 blockchain in MENA, with the technology and financial depth necessary to support large-scale adoption. ADI Chain's modular architecture, which supports optional L3 chains, enables institutions worldwide to launch applications tailored
More news about: ADI Foundation
Dec 09, 2025, 10:17 ET ADI Foundation Announces Launch of ADI Chain's Mainnet and ADI Utility Token
ADI Chain is the first institutional-grade L2 blockchain in MENA, with the technology and financial depth necessary to support large-scale adoption. ADI Chain's modular architecture, which supports optional L3 chains, enables institutions worldwide to launch applications tailored
More news about: ADI Foundation
Dec 09, 2025, 10:00 ET Cision nomina Amy Jones direttrice marketing
PR Newswire – consentono a oltre 75.000 aziende e organizzazioni, tra cui l'84% delle aziende Fortune 500, di vedere ed essere viste, comprendere ed essere comprese dal pubblico che più conta per loro. Contatto con i media Pubbliche
More news about: Cision Ltd.
Dec 09, 2025, 09:49 ET 메나리니 그룹, 2025 샌안토니오 유방암 심포지엄에서 엘라세스트란트(ORSERDU)®의 ER+, HER2- 전이성 유방암(mBC) 환자 대상 2상 병용 요법 데이터 발표
2119발표 날짜 및 시간: 2025년 12월 12일 금요일 오후 12:30 – 2:00장소: Henry B. Convention Center발표 저자: 사라 L. 새먼스(Sara L. Sammons)발표 제목: 호르몬 수용체(HR) 양성, HER2 음성 유방암 환자에서 수술 전 엘라세스트란트와 PULSAR 적응형 방사선 치료를 적용한 2상 연구(HELP Trial)( Hormonal receptor
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 09:44 ET Grubhub's 2025 Delivered Trend Report Confirms America Entered Its Foodmaxxing Era to Get the Most Out of Every Bite and Sip
optimizing their day. Matcha orders on Grubhub jumped 34% as it shifted from a niche wellness drink to a staple energy source. Focused energy + L-theanine calm + aesthetic rituals on your FYP = prime Foodmaxxing territory.AMERICA'S EGG-ERAEggs entered their redemption
More news about: Grubhub
Dec 09, 2025, 09:30 ET 3iQ Appoints Ash Tahbazian as Head of Business Development, Canada
https://www.3iq.io/L:
More news about: 3iQ
Dec 09, 2025, 09:30 ET 3iQ Appoints Ash Tahbazian as Head of Business Development, Canada
https://www.3iq.io/L:
More news about: 3iQ
Dec 09, 2025, 09:13 ET For One Night Only, Michelob ULTRA Is Running It Back To 1980 With An Immersive Reimagining of the 'Miracle on Ice' Game
Instagram. 1Circana MULC+ US L52W Volume w.e 12/7/25Nielsen IQ On Premise Total US volume w.e 10/4/25Contact:
More news about: Michelob ULTRA
Dec 09, 2025, 09:00 ET Parkinson's Foundation Names Centers of Excellence in Ohio and Wisconsin
the lives of the more than one million Americans living with PD by serving communities nationwide," said Parkinson's Foundation President and CEO, John L. Lehr. "These academic medical centers have demonstrated an outstanding commitment to partnership with the Foundation and have taken huge strides to meet
More news about: Parkinson's Foundation
Dec 09, 2025, 08:30 ET DXC Technology Announces Redemption in Full and Delisting of 1.750% Senior Notes due 2026 and Partial Redemption of 1.800% Senior Notes due 2026
Notes due January 2026 (CUSIP No.: 23355L AH9, ISIN No.: XS1883245331 and Common Code: 188324533) (the "2026 Euro Notes") and (ii) partially redeem $300 million aggregate principal amount of DXC's outstanding 1.800% Senior Notes due September 2026 (CUSIP No.: 23355L AL0) (the "2026 USD Notes").
More news about: DXC Technology Company
Dec 09, 2025, 08:00 ET Oral Presentation at ASH 2025 Shows Canopy RTM Cuts Infection-Related Hospitalizations by 52% and Generates Nearly $1M in Annual Savings per 1,000 Patients
Agency for Healthcare Research and Quality (US), 2017 [cited 2025 Oct 27]2 Essell, J. H., Derman, B. A., Kolodziej, M. A., Kwiatkowsky, L., Calkins, G., Parrinello, C. M., & Ascha, M. S. (2024, December 8). Symptoms detection among patients with lymphoid malignancies (LM) using electronic
More news about: Canopy
Dec 09, 2025, 08:00 ET Texas ER Doctor Shares Safety Tips to Keep Young Children Out of the Emergency Room This Christmas
across Texas decorate trees, wrap presents, and prepare to hit the road for holiday family gatherings, Texas emergency room physician, Dr. Christopher L Huerta, MD, is urging parents of infants, toddlers, and young children to keep safety at the top of their Christmas list.
More news about: SignatureCare Emergency Centers
Dec 09, 2025, 08:00 ET Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
ne-breath-technology-platform-and-assets-driving-pipeline-expansion-and-advancing-global-partnership-with-ucb-through-acquired-rights-302636404.htmlSOURCE Lee's Pharmaceutical Holdings Limited
More news about: Lee's Pharmaceutical Holdings Limited
Dec 09, 2025, 07:44 ET Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
of MajesTEC-3, 2025 American Society of Hematology Annual Meeting. Accessed December 2025.2 Mateos, M.V., Moreau, P., Garfall, A. L., van de Donk, N. W. C. J., et al. (2025) Teclistamab plus daratumumab versus standard regimens in relapsed or refractory multiple myeloma: MajesTEC-3
More news about: Johnson & Johnson
Dec 09, 2025, 07:30 ET Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology (ASH) Annual Meeting
ty-of-enjaymo-sutimlimab-jome-in-cold-agglutinin-disease-and-cold-agglutinin-syndrome-cadcas-at-american-society-of-hematology-ash-annual-meeting-302635953.htmlSOURCE Raliance Communications
More news about: Raliance Communications
Dec 09, 2025, 02:50 ET Phase II Data of Cadonilimab Regimen as Neoadjuvant Therapy for Resectable Gastric Cancer Presented at ESMO Asia 2025
system, achieving a dual blockade of the tumor immune suppressive microenvironment. This mechanism provides a stronger anti-tumor effect compared to PD-1/L1 monotherapies.Currently, cadonilimab's clinical value in gastric cancer is scientifically well-established. Beyond its ongoing phase III clinical
More news about: Akeso, Inc.